Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John G Connolly

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Pharmacoepidemiology and Drug Safety|August 1, 2022
A cohort study to assess risk of cutaneous small vessel vasculitis among users of different oral anticoagulantsAdebola Ajao, Austin Cosgrove, Efe Eworuke, et al.
Pharmacoepidemiology and Drug Safety|September 25, 2014
A cross-national comparison of 17 countries' insulin glargine drug labelsJennifer M Polinski, Aaron S Kesselheim, John D Seeger, et al.
Neuroreport|August 2, 2002
Properties of the cellular prion protein expressed in Xenopus oocytesJohn G Connolly, Roth J Tate, Neil F McLennan, et al.
American Journal of Epidemiology|July 8, 2024
A simple Cox approach to estimating risk ratios without sharing individual-level data in multisite studiesDi Shu, Guangyong Zou, Laura Hou, et al.
Biochemical and Biophysical Research Communications|July 30, 2005
Purification of normal cellular prion protein from human platelets and the formation of a high molecular weight prion protein complex following platelet activationMichael Jones, Mark W Head, John G Connolly, et al.
The Diabetes Educator|November 30, 2012
Barriers to insulin progression among patients with type 2 diabetes: a systematic reviewJennifer M Polinski, Benjamin F Smith, Bradley H Curtis, et al.
Primary Care Diabetes|November 27, 2013
Patterns and trends in insulin intensification among patients with type 2 diabetes: a systematic reviewJennifer M Polinski, John G Connolly, Bradley H Curtis, et al.
Brain Pathology (Zurich, Switzerland)|May 30, 2008
An antibody to the aggregated synthetic prion protein peptide (PrP106-126) selectively recognizes disease-associated prion protein (PrP) from human brain specimensMichael Jones, Darren Wight, Victoria McLoughlin, et al.
Current Epidemiology Reports|December 6, 2017
Development and application of two semi-automated tools for targeted medical product surveillance in a distributed data networkJohn G Connolly, Shirley V Wang, Candace C Fuller, et al.
Drug Safety|August 2, 2018
Effect of Lawyer-Submitted Reports on Signals of Disproportional Reporting in the Food and Drug Administration's Adverse Event Reporting SystemJames R Rogers, Ameet Sarpatwari, Rishi J Desai, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Pharmacoepidemiology and Drug Safety|August 1, 2022
A cohort study to assess risk of cutaneous small vessel vasculitis among users of different oral anticoagulantsAdebola Ajao, Austin Cosgrove, Efe Eworuke, et al.
Pharmacoepidemiology and Drug Safety|September 25, 2014
A cross-national comparison of 17 countries' insulin glargine drug labelsJennifer M Polinski, Aaron S Kesselheim, John D Seeger, et al.
Neuroreport|August 2, 2002
Properties of the cellular prion protein expressed in Xenopus oocytesJohn G Connolly, Roth J Tate, Neil F McLennan, et al.
American Journal of Epidemiology|July 8, 2024
A simple Cox approach to estimating risk ratios without sharing individual-level data in multisite studiesDi Shu, Guangyong Zou, Laura Hou, et al.
Biochemical and Biophysical Research Communications|July 30, 2005
Purification of normal cellular prion protein from human platelets and the formation of a high molecular weight prion protein complex following platelet activationMichael Jones, Mark W Head, John G Connolly, et al.
The Diabetes Educator|November 30, 2012
Barriers to insulin progression among patients with type 2 diabetes: a systematic reviewJennifer M Polinski, Benjamin F Smith, Bradley H Curtis, et al.
Primary Care Diabetes|November 27, 2013
Patterns and trends in insulin intensification among patients with type 2 diabetes: a systematic reviewJennifer M Polinski, John G Connolly, Bradley H Curtis, et al.
Brain Pathology (Zurich, Switzerland)|May 30, 2008
An antibody to the aggregated synthetic prion protein peptide (PrP106-126) selectively recognizes disease-associated prion protein (PrP) from human brain specimensMichael Jones, Darren Wight, Victoria McLoughlin, et al.
Current Epidemiology Reports|December 6, 2017
Development and application of two semi-automated tools for targeted medical product surveillance in a distributed data networkJohn G Connolly, Shirley V Wang, Candace C Fuller, et al.
Drug Safety|August 2, 2018
Effect of Lawyer-Submitted Reports on Signals of Disproportional Reporting in the Food and Drug Administration's Adverse Event Reporting SystemJames R Rogers, Ameet Sarpatwari, Rishi J Desai, et al.
Pageof 3